FDA Inspection 1299058 — Peter C. Boldingh, Pharm.D
The FDA completed an inspection of Peter C. Boldingh, Pharm.D on January 9, 2026 in Dilworth, MN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 9, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Dilworth, MN (United States)
Additional Details
Clinical BA/BE